C-peptide is not a simple laboratory test

Authors

DOI:

https://doi.org/10.15277/bjd.2021.312

Keywords:

C-peptide, Diabetes, Therapeutic

References

Pinger CW, Entwistle K, Bell TM, Liu Y, Spence DM. C-peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? Mol Biosyst 2017;13(8):1432–7. https://doi.org/10.1039/C7MB00199A

Danne T, Kordonouri O. Use of technology to potentially preserve C-peptide in type 1 diabetes mellitus. Pediatr Endocrinol Rev 2010;7(Suppl 3):396–400.

Morrison AE, Sim SY, Kong M-F, Gregory R. Type 1 or type 2 diabetes: has the ship already sailed? Br J Diabetes 2021;21:116–9. https://doi.org/10.15277/bjd.2021.297

Washburn RL, Mueller K, Kaur G, et al. C-peptide as a therapy for type 1 diabetes mellitus. Biomedicines 2021;9(3):270. https://doi.org/10.3390/biomedicines9030270

Abdel-Hamid HA, Abdel-Hakeem EA, Zenhom NM, Toni N. C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes. J Physiol Biochem 2020;76(3):417–25. https://doi.org/10.1007/s13105-020-00748-y

Downloads

Published

2021-12-17

Issue

Vol. 21 No. 2 (2021): December 2021

Section

Letters to the editor

License

Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.